CClinicalTrials.gg
CompletedNCT00854334Updated Mar 9, 2018

Co-existent Obstructive Sleep Apnea (OSA) and Obesity: Finding Non-exercise Activity Thermogenesis (NEAT) Targets for Intervention

An observational study in Childhood Obesity and Childhood Obstructive Sleep Apnea, sponsored by Katz, Sherri Lynne, M.D.. Completed at 1 site in Canada. Open to participants aged 10 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-03-09.

Sponsored by Katz, Sherri Lynne, M.D. · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
9
Ages
10 Years to 17 Years
Sex
All
01

Study summary

Rationale: Obesity is an increasing childhood epidemic in Canada. Obstructive sleep apnea (OSA) is a complication of obesity which causes cardiovascular disease, reduced quality of life, and premature death. While the complex interactions between obesity and OSA are not entirely clear, we hypothesize that these conditions may compound each other by:

  1. decreasing physical activity and total energy expenditure by reducing both non-exercise physical pursuits (NEAT- non-exercise activity thermogenesis) and purposeful physical activity.
  2. alterations in the secretion of appetite-controlling hormones, which may lead to increases in energy intake.

Objective: To determine whether the presence of both obesity and OSA in children is associated with a decrease in physical activity and alterations in appetite-regulating hormones greater than those seen in either condition alone or compared to controls.

Methods: Comparison of children 10-17 years with obesity and OSA, obesity alone, OSA alone and neither condition, for the following outcomes: (1) NEAT (kcal/day) (2) Physical activity behavior, appetite regulating hormone profile and self-report appetite assessment.

Unique Aspects: This study combines expertise in sleep medicine, exercise physiology and obesity. Conclusions from this study will better characterize this high-risk clinical population so that innovative strategies targeting improvements in lifestyle behaviors can be developed.

02

Conditions studied

  • Childhood Obesity
  • Childhood Obstructive Sleep Apnea

Keywords

  • Sleep
  • Overweight
  • Physical activity
  • Appetite
  • NEAT
03

In context

Sleep Apnea Syndromes

2,162 studies on the registry are indexed under Sleep Apnea Syndromes; 290 are open to participants now.

This study's enrollment of 9 is below the median of 109 across 654 observational studies indexed under Sleep Apnea Syndromes.

Browse Sleep Apnea Syndromes studies →

Lead sponsor

Katz, Sherri Lynne, M.D. is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Subjects will be recruited from those scheduled to undergo polysomnography in the sleep laboratory at the Children's Hospital of Eastern Ontario

Inclusion criteria

  • age 10-17 years
  • coming for polysomnography at the Children's Hospital of Eastern Ontario

Exclusion criteria

Exclusion Criteria:

  • children receiving treatment for OSA with CPAP (continuous positive airway pressure) or bi-level therapy
  • craniofacial abnormalities
  • genetic syndromes
  • neuromuscular disease
  • tracheostomy
  • medications that may affect appetite or energy balance (systemic corticosteroids)
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
9 participants (actual)
Biospecimen retention
Samples without dna

Groups and cohorts

  • 1.

    Children with both obesity and obstructive sleep apnea

  • 2

    Children without the presence of both obesity and obstructive sleep apnea

06

What researchers measure

Primary outcomes

  1. NEAT (kcal/day)

    Time frame: 10 day period

Secondary outcomes

  1. Physical activity behavior (minutes of moderate-vigorous physical activity as directly measured by accelerometry), appetite regulating hormone profile and self-report appetite assessment.

    Time frame: 10 day period

07

Study locations

1 site
  • Childrens Hospital of Eastern Ontario
    Ottawa, Ontario K1H 8L1, Canada
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 9, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00854334
Lead sponsor
Katz, Sherri Lynne, M.D.
Responsible party
Dr. Sherry Lynn Katz (Katz, Sherri Lynne, M.D., Children's Hospital of Eastern Ontario) — Principal investigator
First posted
Mar 3, 2009
Start date
Sep 2010
Primary completion
Sep 2012
Completion
Dec 2012
Last update
Mar 9, 2018

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion